MichikoNagamineMD
Pathology • Philadelphia, PACytopathology, Anatomic Pathology, Clinical Pathology
Physician
Are you Dr. Nagamine?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 7 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
800 Spruce St
Philadelphia, PA 19107Phone+1 215-829-5933
Summary
- Dr. Michiko Nagamine, MD is a board certified pathologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Nevada and California.
Education & Training
Pennsylvania Hospital of the University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2007 - 2009
Berkshire Medical CenterResidency, Pathology-Anatomic and Clinical, 2002 - 2004
Certifications & Licensure
CA State Medical License 2009 - 2016
NV State Medical License 2010 - 2013
American Board of Pathology Pathology - Anatomic/Pathology - Clinical- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in-Mutated Lung Adenocarcinoma.Yuji Uehara, Hiroki Izumi, Tetsuro Taki, Tetsuya Sakai, Hibiki Udagawa
JTO Clinical and Research Reports. 2025-03-01 - Prognostic value of the international association for the study of lung cancer grading system and its association with the tumor microenvironment in stage I EGFR-muted...Shoko Kubota, Tetsuro Taki, Tomohiro Miyoshi, Kenta Tane, Joji Samejima
European Journal of Cancer. 2024-08-01 - Clinicopathological differences between EGFR mutated and EGFR wild-type lung adenocarcinoma with papillary predominant pattern.Eisuke Goto, Tetsuro Taki, Kotaro Nomura, Yuko Miyakami, Tomohiro Miyoshi
Lung Cancer. 2024-06-01
